Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -6.503M
June 30, 2026 -7.646M
March 31, 2026 -7.894M
December 31, 2025 -6.51M
September 30, 2025 -1.044M
June 30, 2025 -7.091M
March 31, 2025 -1.887M
December 31, 2024 -7.155M
September 30, 2024 3.12M
June 30, 2024 -28.36M
March 31, 2024 -17.99M
December 31, 2023 -15.22M
September 30, 2023 -8.519M
June 30, 2023 -7.73M
Date Value
March 31, 2023 -9.781M
December 31, 2022 -6.015M
September 30, 2022 -11.03M
June 30, 2022 -9.398M
March 31, 2022 -8.149M
December 31, 2021 -9.064M
September 30, 2021 -8.316M
June 30, 2021 -2.385M
March 31, 2021 -5.067M
December 31, 2020 -5.356M
September 30, 2020 -6.731M
June 30, 2020 -5.178M
March 31, 2020 -4.56M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 1.567M
Amgen, Inc. 3.864B
Anika Therapeutics, Inc. -0.311M
BioCryst Pharmaceuticals, Inc. 37.92M
Imunon, Inc. -3.750M